HB676 - Right to Try Act - Individualized Investigational Treatments
Maryland - 2024 Regular Session
Introduced byMatt Morgan, Tiffany T. Alston, Lauren Arikan
Last updated 5 months ago
26 Co-Sponsors
Altering certain provisions of law authorizing certain activity by manufacturers of investigational drugs, biological products, or devices under the Right to Try Act to apply to manufacturers of certain individualized investigational treatments; altering the definition of "eligible patient" under the Right to Try Act to include individuals who have life-threatening or severely debilitating illnesses, rather than only individuals who have terminal illnesses; etc.
STATUS
Passed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity nowError
You must be a resident or registered voter in this state.